TB-500 Identification WADA-funded Ghent University work identified commercial TB-500 as Ac-LKKTETQ and developed metabolism and detection research
10.1183/09031936.95.08050709 12 BatsonB
Target Dose (Monotherapy/Combination): The common target dose used in major clinical trials is 2.4 mg per week
With 3,000+ patients served and a 4.9-star rating across 150+ Google reviews, our approach of combining lab-driven nutrition with peptide therapy consistently produces better outcomes than either intervention alone
Convert carefully when comparing protocols from different sources
This capsule reaches the small intestine (the pH of the intestine is quite high, but unlike the stomachs pH, it does not have an acidic environment that degrades peptides), and once there it dissolves in an environment friendly to peptides, where it is absorbed into the bloodstream